#novo-nordisk

Novo Nordisk

Financial analysis and earnings reports for Novo Nordisk A/S (NVO)

November 8, 20265 min read

Novo Nordisk Q3 2026 Earnings: Sales Up 4%, Reported Profit Down 16% on DKK 8.7B of Write-Downs

Novo Nordisk Q3 2026 sales rose 4% at CER to DKK 79.2B, but DKK 8.7B of impairments, including on its factory network, cut net profit 16% to DKK 16.7B.

Mike Thrift

novo-nordiskopen-ledgerfinancial-analysis

September 14, 202611 min read

Novo Nordisk H1 2026 Earnings: DKK 175.3B Sales, DKK 69.5B Net Profit, Outlook 'Raised' to 0% to −6%

Novo Nordisk's H1 2026 results — DKK 175.3B net sales, DKK 69.5B net profit, Q2 adjusted operating profit up 11% at CER — against full-year guidance of 0% to −6% adjusted growth. A double-entry Beancount breakdown of the 340B rebate bridge, DKK 6.3B impairments, and the GLP-1 franchise's shift from scarcity to pricing pressure.

Mike Thrift

novo-nordiskopen-ledgerfinancial-analysis

Start Free→Documentation